Companies / Vir Biotechnology, Inc.
Vir Biotechnology, Inc.
Financials · FY2025
Ownership
169.2M shares outstanding · as of Jul 29, 2026
Ownership
| Insiders | 1.54% | 2,598,705 |
| 10%+ / strategic | 5.89% | 9,964,151 |
| Institutions | 69.76% | 118,050,374 |
| Public float | 22.81% | 38,602,728 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Sato Vicki LDirector | 0.64% | 1,078,391 |
De Backer MarianneCEOChief Executive Officer · Director | 0.60% | 1,020,704 |
O'Byrne JasonEVP & Chief Financial Officer | 0.10% | 162,615 |
Eisner MarkEVP and Chief Medical Officer | 0.09% | 154,024 |
de Verneuil VaninaEVP, General Counsel, Corp Sec | 0.07% | 112,982 |
Sabatini BrentFormerSVP, Chief Accounting Officer | 0.04% | 61,902 |
More Robert JDirector | 0.03% | 48,656 |
Bischofberger Norbert WDirector | 0.01% | 21,333 |
Coughlin TimothyFormerDirector | <0.01% | 16,000 |
Institutional holders 229
View all →| Holder | Value | % of shares |
|---|---|---|
| $210.71M | 12.22% | |
| $115.73M | 7.63% | |
| $101.53M | 5.89% | |
| $79.10M | 7.75% | |
| $76.62M | 5.05% | |
| $75.67M | 7.42% | |
| $23.82M | 1.57% | |
| $19.05M | 1.87% | |
| $16.16M | 1.58% | |
| $15.29M | 1.50% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Sato Vicki L Director | Sell | Common Stock | $411.3K | -42K -3.55% | 1,144,591 0.68% of shares | medium |
| May 1, 2026 | Sato Vicki L Director | Sell | Common Stock | $221.0K | -22K -2.00% | 1,078,391 0.64% of shares | medium |
| Mar 2, 2026 | Sato Vicki L Director | Sell | Common Stock | $207.2K | -22K -1.90% | 1,122,591 0.66% of shares | medium |
| Apr 1, 2026 | Sato Vicki L Director | Sell | Common Stock | $199.6K | -22K -1.96% | 1,100,391 0.65% of shares | medium |
| Feb 2, 2026 | Sato Vicki L Director | Sell | Common Stock | $169.7K | -22K -1.89% | 1,144,391 0.68% of shares | medium |
| Feb 23, 2026 | De Backer Marianne CEO | Sell | Common Stock | $141.9K | -19K -1.81% | 1,035,466 0.61% of shares | medium |
| Feb 24, 2026 | De Backer Marianne CEO | Sell | Common Stock | $140.7K | -15K -1.43% | 1,020,704 0.60% of shares | medium |
| Feb 25, 2026 | de Verneuil Vanina Executive | Sell | Common Stock | $134.5K | -14K -10.81% | 112,982 0.07% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| State Street Corporation | Passive13G | — |
| Vanguard Group Inc | Passive13G/A | — |
| Sb Investment Advisers (Uk) Ltd | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VIR | — | 92764N102 |